Literature DB >> 8639421

Thrombo-embolic disease after splenectomy for hereditary stomatocytosis.

G W Stewart1, J A Amess, S W Eber, C Kingswood, P A Lane, B D Smith, W C Mentzer.   

Abstract

Nine cases of hereditary stomatocytosis (HSt) are presented which show documented thrombotic complications after splenectomy. In three cases, patients became severely ill with pulmonary hypertension and a fourth developed portal hypertension. One unsplenectomized affected adult relative had suspected but unconfirmed thrombotic pathology; the six other affected unsplenectomized adults did not. Since splenectomy is of only limited therapeutic benefit in stomatocytosis, it should not be performed without careful consideration. A tendency to iron overload, even without hypertransfusion and irrespective of splenectomy, is evident in many of these patients.

Entities:  

Mesh:

Year:  1996        PMID: 8639421     DOI: 10.1046/j.1365-2141.1996.4881033.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  40 in total

1.  Postsplenectomy thromboembolic disease in congenital sideroblastic anaemia.

Authors:  Michael T Byrne; Anke K Bergman; Angela I Ruiz; Bernard J Silver; Jaroslaw P Maciejewski; Ramon V Tiu
Journal:  BMJ Case Rep       Date:  2010-09-17

2.  Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!

Authors:  Mark T Gladwin; Gregory J Kato
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

3.  Splenectomy complicated by sustained extreme thrombocytosis and extensive portosplenomesenteric vein thrombosis in pyrimidine 5'-nucleotidase deficiency.

Authors:  Hassan A Al-Jafar; Ali Taqi; John Patrick Madda; Thamer A Abdullah
Journal:  BMJ Case Rep       Date:  2013-11-28

Review 4.  Inherited hemolytic anemia: a possessive beginner's guide.

Authors:  Narla Mohandas
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

5.  Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.

Authors:  Roberto F Machado; Mark T Gladwin
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

6.  Hereditary xerocytosis: Diagnostic considerations.

Authors:  Mary Risinger; Edyta Glogowska; Satheesh Chonat; Kejian Zhang; Neha Dagaonkar; Clinton H Joiner; Charles T Quinn; Theodosia A Kalfa; Patrick G Gallagher
Journal:  Am J Hematol       Date:  2017-12-23       Impact factor: 10.047

Review 7.  New insights on hereditary erythrocyte membrane defects.

Authors:  Immacolata Andolfo; Roberta Russo; Antonella Gambale; Achille Iolascon
Journal:  Haematologica       Date:  2016-10-18       Impact factor: 9.941

8.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

Review 9.  Erythrocyte disorders in the perinatal period.

Authors:  Laurie A Steiner; Patrick G Gallagher
Journal:  Semin Perinatol       Date:  2007-08       Impact factor: 3.300

10.  PIEZO1 gene mutation in a Japanese family with hereditary high phosphatidylcholine hemolytic anemia and hemochromatosis-induced diabetes mellitus.

Authors:  Shinsaku Imashuku; Hideki Muramatsu; Takashi Sugihara; Yusuke Okuno; Xinan Wang; Kenichi Yoshida; Ayako Kato; Koichi Kato; Yasuaki Tatsumi; Ai Hattori; Shinya Kita; Keishi Oe; Atsushi Sueyoshi; Takeshi Usui; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Hitoshi Kanno
Journal:  Int J Hematol       Date:  2016-03-14       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.